Plague as a biological weapon: Medical and public health management

JAMA

Volumn 283, Issue 17, 2000, Pages 2281-2290

  Inglesby, Thomas V ^a,i   Dennis, David T ^c   Henderson, Donald A ^b   Bartlett, John G ^a   Ascher, Michael S ^j   Eitzen, Edward ^d   Fine, Anne D ^f   Friedlander, Arthur M ^d   Hauer, Jerome ^e   Koerner, John F ^b   Layton, Marcelle ^f   McDade, Joseph ^j   Osterholm, Michael T ^h   O'Toole, Tara ^b   Parker, Gerald ^d   Perl, Trish M ^a   Russell, Philip K ^b   Schoch Spana, Monica ^b   Tonat, Kevin ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Public Health   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^e SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^f New York City Health Department   (United States)

^g U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^h Infect Control Advisory Network Inc   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFAZOLIN; CEFOTETAN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; SULFADIAZINE; SULFAMERAZINE; SULFATHIAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BIOLOGICAL WARFARE; COUGHING; DATA BASE; FEVER; HEMOPTYSIS; INFECTION CONTROL; MORTALITY; PLAGUE; PRIORITY JOURNAL; SEPTIC SHOCK; THORAX PAIN; TREATMENT PLANNING; VACCINATION; YERSINIA PESTIS;

EID: 0034600229     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.283.17.2281     Document Type: Article

References (72)

1. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management JAMA. 1999;281:1735-1745.
2. Henderson DA, Inglesby TV, Bartlett JG, et al. Small-pox as a biological weapon: medical and public health management. JAMA. 1999;281:2127-2137.
3. Centers for Disease Control and Prevention. Critical Biological Agents for Public Health Preparedness: Summary of Selection Process and Recommendations. October 16, 1999. Unpublished report.
4. Perry RD, Fetherston JD. Yersinia pestis -etiologic agent of plague. Clin Microbiol Rev. 1997; 10:35-66.
5. Slack P. The black death past and present. Trans R Sod Trop Med Hyg. 1989;83:461-463.
6. Harris SH. Factories of Death. New York, NY: Routledge; 1994:78, 96.
7. Health Aspects of Chemical and Biological Weapons. Geneva, Switzerland: World Health Organization; 1970:98-109
8. Alibek K, Handelman S. Biohazard. New York, NY: Random House; 1999.
9. Hughes J. Nation's Public Health Infrastructure Regarding Epidemics and Bioterrorism [congressional testimony]. Washington, DC: Appropriations Committee, US Senate; June 2, 1998.
10. Carus WS. Bioterrorism and Biocrimes: The Illicit Use of Biological Agents in the 20th Century. Washington, DC: Center for Counterproliferation Research, National Defense University; 1998.
11. Dennis D, Meier F. Plague. In: Horsburgh CR, Nelson AM, eds. Pathology of Emerging Infections. Washington, DC: ASM Press; 1997:21-47.
12. Centers for Disease Control and Prevention. Fatal human plague. MMWR Morb Mortal Wkly Rep. 1997;278:380-382.
13. Centers for Disease Control and Prevention. Human plague-United States, 1993-1994. MMWR Morb Mortal Wkly Rep. 1994;43:242-246.
14. Meyer K. Pneumonic plague. Bacteriol Rev. 1961; 25:249-261.
15. Kellogg WH. An epidemic of pneumonic plague Am J Public Health. 1920;10:599-605.
16. Wu L-T. A Treatiseon Pneumonic Plague. Geneva, Switzerland: League of Nations Health Organization, 1926.
17. Chernin E. Richard Pearson Strong and the Manchurian epidemic of pneumonic plague, 1910-1911. J Hist Med Allied Sci. 1989;44:796-319.
18. Ratsitorahina M, Chanteau S, Rahalison L, Ratisofasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet. 2000;355:111-113.
19. Speck RS, Wolochow H. Studies on the experimental epidemiology of respiratory infections: experimental pneumonic plague in Macaccus rhesus. J Infect Dis. 1957;100:58-69.
20. Aleksic S, Bockemuhl J. Yersinia and other enterobacteriaceae. In: Murray P, ed. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology; 1999:483-496.
21. Butler T. Yersinia species (including plague). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. New York, NY: Churchill Livingstone; 1995:2070-2078.
22. McGovernTW, Friedlander A. Plague. In: Zajtchuk R, Bellamy RF, eds. Medical Aspects of Chemical and Biological Warfare. Bethesda, Md: Office of the Surgeon General; 1997:479-502.
23. Campbell GL, Dennis DT. Plague and other Yersinia infections In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 1998: 975-983.
24. Centers for Disease Control and Prevention. Pneumonic plague - Arizona. MMWR Morb Mortal Wkly Rep. 1992;41:737-739.
25. Werner SB, Weidmer CE, Nelson BC, Nygaard GS, Goethals RM, Poland JD. Primary plague pneumonia contracted from a domestic cat in South Lake Tahoe, California. JAMA. 1984;251:929-931.
26. Finegold MJ, Petery JJ, Berendt RF, Adams HR. Studies on the pathogenesis of plague. J Infect Dis. 1968;53:99-114.
27. Poland JD, Dennis DT. Plague. In: Evans AS, Brachman PS, eds. Bacterial Infections of Humans: Epidemiology and Control. New York, NY: Plenum Medical Book Co; 1998:545-558.
28. Institute of Medicine National Research Council. Detection and measurement of biological agents. In: Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. Washington, DC: National Academy Press; 1999:95.
29. American Public Health Association. Plague. In: Benenson AS, ed. Control of Communicable Diseases Manual. Washington, DC: American Public Health Association; 1995:353-358.
30. Wilmoth BA, Chu MC, Quan TC. Identification of Yersinia pestis by BBL crystal enteric/nonfermenter identification system. J Clin Microbiol. 1996;34:2829-2830.
31. Centers for Disease Control and Prevention. Prevention of plague: recommendations of the Advisory Committee on Immunization Practice (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45(RR-14):1-15.
32. Titball RW, Eley S, Williamson ED, Dennis DT. Plague. In: Plotkin S, Mortimer EA, eds. Vaccines. Philadelphia, Pa: WB Saunders; 1999:734-742.
33. McCrumb FR, Mercier S, Robic J, et al. Chloramphenicol and terramycin in the treatment of pneumonic plague. Am J Med. 1953;14:284-293.
34. Barnes AM, Quan TJ. Plague. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia, Pa: WB Saunders Co; 1992:1285-1291.
35. American Hospital Formulary Service. AHFS Drug Information. Bethesda, Md: American Society of Health System Pharmacists; 2000.
36. Wong TW. Plague in a pregnant patient. Trop Dort. 1986;16:187-188.
37. Lewiecki EM. Primary plague septicemia. Rocky Mt Med J. 1978;75:201-202.
38. Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona. West J Med. 1985; 142:641-646.
39. Crook LD, Tempest B. Plague: a clinical review of 27 cases. Arch Intern Med. 1992;152:1253-1256.
40. Committee on Infectious Diseases. Plague. In: Peter G, ed. 1997 Redbook, Elk Grove Village, Ill: American Academy of Pediatrics; 1997:408-410.
41. Smith MD, Vinh SX, Hoa NT, Wain J, Thung D, White NJ. In vitro antimicrobial susceptibilities of strains of Yersinia pestis. Antimicrob Agents Chemother. 1995;39:2153-2154.
42. Byrne WR, Welkos SL, Pitt ML, et al. Antibiotic treatment of experimental pneumonic plague in mice. Antimicrob Agents Chemother. 1998;42:675-681.
43. Lyamuya EF, Nyanda P, Mohammedali H, Mhalu FS. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania. J Trop Med Hyg. 1992;95:335-338.
44. Bonacorsi SP, Scavizzi MR, Guiyoule A, Amouroux JH, Carniel E. Assessment of a fluoroquinolone, three β-lactams, two aminoglycosides, and a cycline in the treatment of murine Yersinia pestis infection. Antimicrob Agents Chemother. 1994;38:481-486.
45. Rasoamanana B, Coulanges P, Michel P, Rasolofonirina N. Sensitivity of Yersinia pestis to antibiotics: 277 strains isolated in Madagascar between 1926 and 1989. Arch Inst Pasteur Madagascar. 1989;56: 37-53.
46. Makarovskaia LN, Shcherbaniuk AI, Ryzhkova VV, Sorokina TB. Effectiveness of doxycycline in experimental plague. Antibiot Khimioter. 1993;38:48-50.
47. Samokhodkina ED, Ryzhko IV, Shcherbaniuk AI, Kasatkina IV, Tsuraeva RI, Zhigalova TA. Doxycycline in the prevention of experimental plague induced by plague microbe variants. Antibiot Khimioter. 1992;37:26-28.
48. 1-phenotype plague microbe. Antibiot Khimioter. 1998;43:24-28.
49. Davis KJ, Fritz DL, Pitt ML, Welkos SL, Worsham PL, Friedlander A. Pathology of experimental pneumonic plague produced by fraction-1 positive and fraction-1 negative Yersinia pestis in African Green Monkeys. Arch Pathol Lab Med. 1996;120:156-163.
50. Russell P, Eley SM, Green M, et al. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother. 1998;41: 301-305.
51. Russell P, Eley SM, Bell DL, Manchee RJ, Titball RW. Doxycycline or ciprofloxacin prophylaxis and therapy against experimental Y. pestis infection in mice. J Antimicrob Chemother. 1996;37:769-774.
52. Butler T. Plague, In: Strickland GT, ed. Tropical Medicine. Philadelphia, Pa: WB Saunders Co; 1991: 408-416.
53. Expert Committee on Plague. Geneva, Switzerland: World Health Organization: 1959. Technical Report Series 165.
54. Burkle FM. Plague as seen in South Vietnamese children. Clin Pediatr. 1973;12:291-298.
55. Frean JA, Arntzen L, Capper T, Bryskier A, Klugman KP. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a Southern African plague focus. Antimicrob Agents Chemother. 1996;40:2646-2647.
56. Brygoo ER, Gonon M. Une epidemie de peste pulmonaire dans le Nor-Est de Madagascar. Bull Soc Pathol Exot. 1958;51:47-66.
57. Nguyen VI, Nguyen DH, Pham VD, Nguyen VL. Peste bubonique et septicemique traitée avec succes par du trimethoprime-sulfamethoxazole. Bull Soc Pathol Exot. 1972;769-779.
58. Butler TJ, Levin J, Linh NN, Chau DM, Adickman M, Arnold K. Yersinia pestis infection in Vietnam. J Infect Dis. 1976;133:493-499.
59. WHO Expert Committee on Plague: Third Report. Geneva, Switzerland: World Health Organization; 1970:1-25. Technical Report Series 447.
60. Galimand M, Guiyoule A, Gerbaud G, et al. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N Engl J Med. 1997;337:677-680.
61. Ryzhko IV, Shcherbaniuk AI, Samokhodkina ED, et al. Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra-phenotypes. Antibiot Khimioter. 1994;39: 32-36.
62. Scott JL, Finegold SM, Belkin GA, et al. A controlled double blind study of the hematologic toxicity of chloramphenicol. N Engl J Med. 1965;272: 113-142.
63. Watterberg KL, Kelly HW, Angelus P, Backstrom C. The need for a loading dose of gentamicin in neonates. Ther Drug Monit. 1989;11:16-20.
64. Consensus Report of the International Society of Chemotherapy Commission: use of fluoroquinolones in pediatrics. Pediatr Infect Dis J. 1995;14:1-9.
65. Sakala E. Obstetrics and Gynecology. Baltimore, Md: Williams & Wilkins; 1997:945.
66. Cziel A, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynecol. 1997;89:524-528.
67. Garner JS. Guidelines for isolation precautions in hospitals: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996; 17:53-80.
68. Burmeister RW, Tigertt WD, Overholt EL. Laboratory-acquired pneumonic plague. Ann Intern Med. 1962;56:789-800.
69. Morse S, McDade J. Recommendations for working with pathogenic bacteria. Methods Enzymol. 1994; 235:1-26.
70. Safety Measures for Use in Outbreaks in Communicable Disease Outbreaks. Geneva, Switzerland: World Health Organization; 1986.
71. Gershon RR, Vlahov D, Cejudo JA, et al. Tuberculosis risk in funeral home employees. J Occup Environ Med. 1998;40:497-503.
72. Freeman BA. Yersinia; Pasturella; Francisella, Actinobacillus. In: Textbook of Microbiology. Philadelphia, Pa: WB Saunders Co; 1985:513-530.